These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1149368)

  • 1. Methadone in man: pharmacokinetic and excretion studies in acute and chronic treatment.
    Verebely K; Volavka J; Mulé S; Resnick R
    Clin Pharmacol Ther; 1975 Aug; 18(2):180-90. PubMed ID: 1149368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of pharmacokinetics to pharmacological activity: morphine, methadone and naloxone.
    Berkowitz BA
    Clin Pharmacokinet; 1976; 1(3):219-30. PubMed ID: 13957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of methadone in man after a single oral dose.
    Inturrisi CE; Verebely K
    Clin Pharmacol Ther; 1972; 13(6):923-30. PubMed ID: 5081605
    [No Abstract]   [Full Text] [Related]  

  • 4. Naltrexone: disposition, metabolism, and effects after acute and chronic dosing.
    Verebey K; Volavka J; Mulé SJ; Resnick RB
    Clin Pharmacol Ther; 1976 Sep; 20(3):315-28. PubMed ID: 954353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single dose pharmacokinetics and bioavailability of methadone in man studied with a stable isotope method.
    Meresaar U; Nilsson MI; Holmstrand J; Anggård E
    Eur J Clin Pharmacol; 1981; 20(6):473-8. PubMed ID: 7286059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of methadone in methadone maintenance.
    Anggård E; Gunne LM; Homstrand J; McMahon RE; Sandberg CG; Sullivan HR
    Clin Pharmacol Ther; 1975 Mar; 17(3):258-66. PubMed ID: 1120392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain.
    Inturrisi CE; Colburn WA; Kaiko RF; Houde RW; Foley KM
    Clin Pharmacol Ther; 1987 Apr; 41(4):392-401. PubMed ID: 3829576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma l-alpha-Acetylmethadol (LAAM) after acute and chronic administration.
    Henderson GL; Wilson BK; Lau DH
    Clin Pharmacol Ther; 1977 Jan; 21(1):16-25. PubMed ID: 832446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of desipramine treatment on the biliary, fecal and urinary excretion of methadone in the rat.
    Liu SJ; Chen KZ; Wang RI
    J Pharmacol Exp Ther; 1976 Aug; 198(2):308-17. PubMed ID: 948028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effects and pharmacokinetics of racemic methadone and its optical isomers.
    Olsen GD; Wendel HA; Livermore JD; Leger RM; Lynn RK; Gerber N
    Clin Pharmacol Ther; 1977 Feb; 21(2):147-57. PubMed ID: 837634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of methadone.
    Nilsson MI; Meresaar U; Anggård E
    Acta Anaesthesiol Scand Suppl; 1982; 74():66-9. PubMed ID: 6953740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of methadone during maintenance therapy: pulse labeling with deuterated methadone in the steady state.
    Anggård E; Nilsson MI; Holmstrand J; Gunne LM
    Eur J Clin Pharmacol; 1979 Aug; 16(1):53-7. PubMed ID: 499301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methadone-disulfiram interaction during methadone maintenance.
    Tong TG; Benowitz NL; Kreek MJ
    J Clin Pharmacol; 1980; 20(8-9):506-13. PubMed ID: 7430415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute i.v. Methadone Kinetics in Man: relationship to chronic studies.
    Bullingham RE; McQuay HJ; Porter JB; Thomas D; Allen MC; Moore RA
    Br J Anaesth; 1982 Dec; 54(12):1271-6. PubMed ID: 7171415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol and the steady-state disposition kinetics of methadone in rats.
    Tommasello AC; Adir J
    J Stud Alcohol; 1984 Mar; 45(2):155-9. PubMed ID: 6727376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone disposition in patients with chronic liver disease.
    Novick DM; Kreek MJ; Fanizza AM; Yancovitz SR; Gelb AM; Stenger RJ
    Clin Pharmacol Ther; 1981 Sep; 30(3):353-62. PubMed ID: 7273599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of acetylmethadol in relation to pharmacologic action.
    Kaiko RF; Inturrisi CE
    Clin Pharmacol Ther; 1975 Jul; 18(1):96-103. PubMed ID: 238782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methadone maintenance: effect of urinary pH on renal clearance in chronic high and low doses.
    Bellward GD; Warren PM; Howald W; Axelson JE; Abbott FS
    Clin Pharmacol Ther; 1977 Jul; 22(1):92-9. PubMed ID: 17500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of urinary pH on the disposition of methadone in man.
    Nilsson MI; Widerlöv E; Meresaar U; Anggård E
    Eur J Clin Pharmacol; 1982; 22(4):337-42. PubMed ID: 6286317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of acute and chronic methadone treatment on the in vitro N-demethylation of methadone by microsomal enzymes of male and pregnant and nonpregnant female rats.
    Peters MA
    Arch Int Pharmacodyn Ther; 1973 Oct; 205(2):259-66. PubMed ID: 4148831
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.